From Casetext: Smarter Legal Research

Novo Nordisk Inc. v. Aurobindo Pharma Ltd.

United States Court of Appeals for the Federal Circuit
Sep 26, 2012
2012-1388 (Fed. Cir. Sep. 26, 2012)

Opinion

2012-1388

09-26-2012

NOVO NORDISK INC. AND NOVO NORDISK A/S, Plaintiffs-Appellants, v. AUROBINDO PHARMA LTD. AND AUROBINDO PHARMA USA, INC., Defendants-Appellees.


NOTE: This order is nonprecedential.


Appeal from the United States District Court for the

District of New Jersey in case no. 12-CV-1026, Judge

Freda L. Wolfson.


ON MOTION


ORDER

The parties jointly move to stay proceedings in this appeal pending the final disposition of Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Ltd., No. 2011-1223.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The motion to stay proceedings in 2012-1388 is granted. The parties are directed to inform this court within 10 days of the final disposition of 2011-1223 how they believe this appeal should proceed.

(2) A copy of this order shall be transmitted to the merits panel assigned to Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Ltd., No. 2011-1223.

FOR THE COURT

_____________

Jan Horbaly

Clerk
cc: Mark Andrew Perry, Esq.

Edward John Pardon, Esq.
s26


Summaries of

Novo Nordisk Inc. v. Aurobindo Pharma Ltd.

United States Court of Appeals for the Federal Circuit
Sep 26, 2012
2012-1388 (Fed. Cir. Sep. 26, 2012)
Case details for

Novo Nordisk Inc. v. Aurobindo Pharma Ltd.

Case Details

Full title:NOVO NORDISK INC. AND NOVO NORDISK A/S, Plaintiffs-Appellants, v…

Court:United States Court of Appeals for the Federal Circuit

Date published: Sep 26, 2012

Citations

2012-1388 (Fed. Cir. Sep. 26, 2012)